Solvay is to close a deal to sell its entire pharmaceutical business to Abbott for €5.2 bln in Q1-2010. The deal is subject to approval by the relevant competition authorities. Money raised by the salle will be invested in strategic projects in chemicals and plastics.
For more details on Solvay to sell entire pharmaceutical business to Abbott, to invest in plastics click here
Tuesday, September 29, 2009
Solvay to sell entire pharmaceutical business to Abbott, to invest in plastics
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment